KPV peptide is rapidly gaining recognition in the research world as a potent anti-inflammatory solution, especially for effortless gut and skin healing. As an alpha-msh-fragment, KPV stands out among modern peptides because of its ability to gently calm overactive immune responses without causing harmful side effects. If you’ve spent time exploring new therapies to support healthy immunity, manage chronic inflammation, or restore GI and skin integrity, KPV peptide’s promise is hard to overlook.
Updated on March 4, 2026 — references verified, newer research added.
Understanding KPV Peptide: An Alpha-MSH-Fragment with Unique Healing Power
KPV is a short peptide sequence (Lysine-Proline-Valine) derived from the larger melanocyte-stimulating hormone (alpha-MSH). Research on the alpha-msh-fragment family―and KPV in particular―has spotlighted its anti-inflammatory, healing, and immune-calming effects. Unlike broad-spectrum immunosuppressants, which can blunt the entire immune system, KPV works with your body’s natural defenses to soothe inflammation at the source【1】. Foundational pharmacological work established that KPV’s anti-inflammatory mechanism differs from other MSH peptides and does not require binding to classical melanocortin receptors, operating instead through direct cytokine inhibition【2】.
What Makes KPV a Unique Anti-Inflammatory?
While many compounds claim anti-inflammatory magic, KPV’s mechanism is both targeted and gentle. This peptide specifically interferes with pro-inflammatory cytokines like TNF-alpha and IL-6, crucial signals driving chronic inflammation in the gut and the skin. KPV also appears to modulate the NF-κB pathway―a master switch for inflammation, immunity, and cellular stress responses【3】. A key mechanistic advance confirmed in peer-reviewed research is that KPV is actively transported into intestinal epithelial cells by the PepT1 (SLC15A1) transporter at nanomolar concentrations, where it suppresses NF-κB and MAPK signaling and reduces expression of IL-6, IL-12, TNF-alpha, IFN-gamma, and IL-1β【3】.
The result? Inflammation is calmed where it starts, without shutting down your body’s vital healing and defense mechanisms. For scientists probing novel therapies for autoimmune flare-ups, irritative dermatitis, or persistent gut discomfort, KPV peptide is a compelling focus.
KPV Peptide for Gut Healing: Research Highlights
The gut is a battlefield of complex immune activity. Dietary antigens, pathogens, and stress can easily trigger a cascade of inflammation that lingers, producing symptoms like leaky gut, food sensitivities, and even IBD (inflammatory bowel disease). KPV peptide steps in, guided by its origin as an alpha-msh-fragment, with a calming presence.
Studies have shown KPV effectively reduces pro-inflammatory cytokines in gut epithelial cells, shields the integrity of the gut lining, and accelerates functional healing after injury【3】【4】. This makes it invaluable in experimental models of colitis, where inflammation and tissue damage are pronounced. In murine DSS and TNBS colitis models, KPV reduced colonic myeloperoxidase activity by approximately 50% and significantly decreased inflammatory infiltrates, rescuing animals from colitis-induced mortality【4】. More recent research has further extended these findings, demonstrating that KPV prevents colitis-associated carcinogenesis in a PepT1-dependent manner【5】. A 2024 study combined KPV with FK506 in a nanoparticle formulation targeting PepT1, achieving synergistic reduction in disease activity index, improved colon length, and suppressed inflammatory cytokine production beyond what either agent achieved alone【6】. For a fully synergistic approach, explore our “KLOW” blend combining BPC-157, TB-500, GHK-Cu, and KPV―formulated strictly for research purposes.
Effortless Skin Healing: How KPV Transforms Topical Recovery
Your skin, being the body’s front-line barrier, is continually challenged by environmental stressors. Persistent inflammation can lead to redness, itching, dermatitis, or even slow wound healing. KPV peptide, through its anti-inflammatory prowess, helps restore balance for healthier skin【7】.
As a fragment of alpha-msh, KPV suppresses the release of histamine, calms the cutaneous immune system, and hinders the oxidative stress that fuels chronic skin issues. A 2025 study demonstrated that KPV protects keratinocytes from particulate matter (PM10)-induced inflammation and apoptosis by suppressing MAPK (ERK and p38) and NF-κB pathways, reducing IL-1β secretion and reactive oxygen species, and modulating Bax/Bcl-2/caspase-3 expression【8】. Research on dermal delivery confirms that while passive skin penetration is limited, microneedle pretreatment and iontophoresis significantly enhance transdermal KPV flux for topical research applications【9】. These findings make KPV an exciting tool for research on eczema, psoriasis, and slow-healing wounds.
For advanced peptide healing research, synergistic blends like BPC-157/TB-500 and “KLOW” offer powerful multi-pathway support.
Mechanisms of Action: How KPV Peptide Calms Immunity & Fosters Healing
At the heart of KPV’s therapeutic potential is its modulation of the innate immune response:
– Blocks Pro-Inflammatory Cytokines: Key inflammatory messengers, including TNF-alpha and IL-1β, are downregulated【3】.
– Preserves Barrier Integrity: KPV helps maintain and restore tight junctions in both gut and skin epithelia―crucial for stopping the “leak” that inflames tissues.
– Reduces Oxidative Stress: As an alpha-msh-fragment, KPV chokes off free radicals in inflammation hotspots, reducing cell and DNA damage【8】.
– PepT1-Dependent Uptake: KPV is actively transported via the intestinal PepT1 transporter, achieving efficacy at nanomolar concentrations【3】【5】.
It’s no wonder scientists are exploring KPV across experimental models of IBD, dermatitis, and even post-surgical healing!
KPV and Immunity: Trustworthy Support Without Suppression
Chronic inflammation doesn’t just feel uncomfortable―it exhausts your immune defenses. KPV, rather than shutting the immune system down (like steroids), gently restores immune balance:
– Shifts immune cells from “attack mode” to “regulate and repair” mode.
– Limits overactivation of mast cells and histamine release―key for both gut and skin healing.
– Supports tissue regeneration for sustained, natural healing【2】【10】.
A 2023 comprehensive review in Cells confirmed that the melanocortin system, including KPV, exerts its anti-IBD effects through both MC1R-dependent and independent pathways, with PepT1 upregulation during active colitis further enhancing KPV’s bioavailability at sites of intestinal inflammation【10】. This makes KPV an ideal peptide for gut and skin immunity research.
Anti-Inflammatory Peptides vs. Traditional Anti-Inflammatories
Steroids, NSAIDs, and even some monoclonal antibodies can quash systemic inflammation but often come with tradeoffs―immune suppression, poor gut healing, or delayed wound closure. KPV, as a naturally occurring alpha-msh-fragment, provides a gentler approach. It works within your body’s own renewal systems, encouraging natural defense and repair without harsh side-effects.
Researchers have begun combining KPV with BPC-157 and TB-500 for more comprehensive results. Discover our BPC-157 Capsules and BPC-157/TB-500 Blend for parallel research lines.
KPV in Research: Cutting-Edge Discoveries & Future Promise
With growing evidence, KPV peptide is inspiring researchers across multiple fields:
– Gastroenterology: Studies confirm KPV reduces the severity of colitis and accelerates mucosal repair in animal models via PepT1-mediated NF-κB and MAPK suppression【3】【4】.
– Oncology: Research demonstrates KPV prevents colitis-associated carcinogenesis in a PepT1-dependent mechanism, suggesting potential in cancer prevention research【5】.
– Dermatology: KPV suppresses keratinocyte apoptosis and inflammation from environmental stressors and shows promise for eczema, psoriasis, and wound healing research【8】.
– Inflammation Science: KPV’s ability to quiet the NF-κB pathway via a receptor-independent mechanism sets it apart for labs investigating chronic inflammatory states【2】【10】.
Further research is exploring oral, topical, and injectable KPV protocols, plus synergistic blends. A 2024 peptide therapeutics review identified KPV as a leading candidate among gut-targeted anti-inflammatory peptides due to its PepT1 affinity and mucosal delivery potential【11】.
The Safety & Compliance Landscape: Only for Research Use
It’s crucial to stress: All products mentioned, including KPV, are strictly for research purposes and not for human or animal use. This ensures ethical compliance as the field advances.
How to Incorporate KPV Peptide in Research Studies
Studying KPV peptide is straightforward, thanks to its stability and solubility. Many labs pair KPV with bacteriostatic water for precision dosing in in vitro and animal studies. For combined pathway analysis, see our “KLOW” blend, or explore classic staples like BPC-157/TB-500.
Q: What is the primary benefit of KPV peptide as an anti-inflammatory?
A: KPV peptide’s main benefit is its targeted ability to reduce inflammation by blocking pro-inflammatory cytokines and suppressing NF-κB and MAPK pathways without suppressing normal immune repair.
Q: How does KPV support gut healing?
A: By calming cytokine activity and restoring gut barrier integrity via PepT1-mediated transport, KPV helps reduce leaky gut, soothe irritation, and accelerate mucosal repair in research models.
Q: Can KPV peptide be used for skin healing?
A: Yes, in research settings KPV has shown promise in reducing skin irritation, protecting keratinocytes from oxidative stress-induced apoptosis, and supporting faster wound healing.
Q: Are KPV products intended for human or animal use?
A: No. All KPV peptides offered by OathPeptides.com are strictly for research purposes only.
Q: Which other peptides pair well with KPV in research studies?
A: KPV combines well with BPC-157, TB-500, and GHK-Cu for comprehensive tissue repair and anti-inflammatory studies. See our “KLOW” Blend for a research-ready solution.
Conclusion: Advancing Gut & Skin Healing Research with KPV Peptide
KPV peptide, as a powerful anti-inflammatory agent and alpha-msh-fragment, holds incredible potential for advancing gut and skin healing studies. Whether investigating new solutions for chronic inflammation or optimizing healing protocols, KPV’s unique immune-calming effect, demonstrated efficacy in experimental colitis and skin inflammation models, and synergy with peptides like BPC-157 and TB-500 make it an indispensable tool for peptide science.
Browse OathPeptides.com for KPV peptide and combinations like “KLOW” for your next inflammatory or regenerative research project. Remember: All products are strictly for research purposes and not for human or animal use.
References
1. Brzoska, T. et al. (2008). The immunomodulatory role of melanocortins in skin and gut inflammation. Endocrine. Link.
2. Getting, S.J., Schioth, H.B., & Perretti, M. (2003). Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. Journal of Pharmacology and Experimental Therapeutics, 306(2), 631–637. PMID 12750433.
3. Dalmasso, G., Charrier-Hisamuddin, L., Nguyen, H.T.T., Yan, Y., Sitaraman, S., & Merlin, D. (2008). PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Gastroenterology, 134(1), 166–178. PMID 18061177.
4. Kannengiesser, K., Maaser, C., Heidemann, J., et al. (2008). Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases, 14(3), 324–331. PMID 18092346.
5. Viennois, E., Ingersoll, S.A., Ayyadurai, S., et al. (2016). Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of KPV in a murine model. Cellular and Molecular Gastroenterology and Hepatology, 2(3), 340–357. PMID 27458604.
6. Zhang, D., Jiang, L., Yu, F., et al. (2024). PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of DSS-induced colitis. Frontiers in Pharmacology. DOI: 10.3389/fphar.2024.1442876.
7. Morandini, R. et al. (2006). The Role of α-MSH in the Regulation of Peripheral Inflammation. Peptides, 27(2): 339–348.
8. Unnamed authors (2025). Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. Food and Chemical Toxicology. Link.
9. Pawar, K. & Kolli, C.S. (2017). Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin. Journal of Pharmaceutical Sciences. PMID 28343991.
10. Gravina, A.G., Pellegrino, R., Durante, T., et al. (2023). The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials. Cells. PMID 37508552.
11. Ge, C., Wang, Z., Wang, Y., & Wei, M. (2024). Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions. Review. PMID 40686644.
Looking for an anti-inflammatory that supports gut healing, radiant skin, and robust immunity? Discover how KPV peptide, a unique alpha-msh-fragment, offers powerful healing benefits without unwanted side effects.
Can peptides cause immunogenicity? Yes, peptides can trigger immune responses in some cases. Understanding this interaction between peptides and your immune system is crucial for both research and therapeutic applications. Let’s explore what you need to know about peptide immunogenicity. What Is Peptide Immunogenicity? Immunogenicity refers to your body’s immune response to a foreign substance. …
Discover how GH-releasing Tesamorelin powerfully targets stubborn visceral fat and supercharges metabolism, making it an exciting focus in body composition and peptide research. With its proven impact on lipolysis and IGF-1 levels, Tesamorelin offers researchers new insight into unlocking healthier metabolic pathways.
KPV Peptide: Powerful Anti-Inflammatory for Effortless Gut & Skin Healing
KPV peptide is rapidly gaining recognition in the research world as a potent anti-inflammatory solution, especially for effortless gut and skin healing. As an alpha-msh-fragment, KPV stands out among modern peptides because of its ability to gently calm overactive immune responses without causing harmful side effects. If you’ve spent time exploring new therapies to support healthy immunity, manage chronic inflammation, or restore GI and skin integrity, KPV peptide’s promise is hard to overlook.
Updated on March 4, 2026 — references verified, newer research added.
Understanding KPV Peptide: An Alpha-MSH-Fragment with Unique Healing Power
KPV is a short peptide sequence (Lysine-Proline-Valine) derived from the larger melanocyte-stimulating hormone (alpha-MSH). Research on the alpha-msh-fragment family―and KPV in particular―has spotlighted its anti-inflammatory, healing, and immune-calming effects. Unlike broad-spectrum immunosuppressants, which can blunt the entire immune system, KPV works with your body’s natural defenses to soothe inflammation at the source【1】. Foundational pharmacological work established that KPV’s anti-inflammatory mechanism differs from other MSH peptides and does not require binding to classical melanocortin receptors, operating instead through direct cytokine inhibition【2】.
What Makes KPV a Unique Anti-Inflammatory?
While many compounds claim anti-inflammatory magic, KPV’s mechanism is both targeted and gentle. This peptide specifically interferes with pro-inflammatory cytokines like TNF-alpha and IL-6, crucial signals driving chronic inflammation in the gut and the skin. KPV also appears to modulate the NF-κB pathway―a master switch for inflammation, immunity, and cellular stress responses【3】. A key mechanistic advance confirmed in peer-reviewed research is that KPV is actively transported into intestinal epithelial cells by the PepT1 (SLC15A1) transporter at nanomolar concentrations, where it suppresses NF-κB and MAPK signaling and reduces expression of IL-6, IL-12, TNF-alpha, IFN-gamma, and IL-1β【3】.
The result? Inflammation is calmed where it starts, without shutting down your body’s vital healing and defense mechanisms. For scientists probing novel therapies for autoimmune flare-ups, irritative dermatitis, or persistent gut discomfort, KPV peptide is a compelling focus.
KPV Peptide for Gut Healing: Research Highlights
The gut is a battlefield of complex immune activity. Dietary antigens, pathogens, and stress can easily trigger a cascade of inflammation that lingers, producing symptoms like leaky gut, food sensitivities, and even IBD (inflammatory bowel disease). KPV peptide steps in, guided by its origin as an alpha-msh-fragment, with a calming presence.
Studies have shown KPV effectively reduces pro-inflammatory cytokines in gut epithelial cells, shields the integrity of the gut lining, and accelerates functional healing after injury【3】【4】. This makes it invaluable in experimental models of colitis, where inflammation and tissue damage are pronounced. In murine DSS and TNBS colitis models, KPV reduced colonic myeloperoxidase activity by approximately 50% and significantly decreased inflammatory infiltrates, rescuing animals from colitis-induced mortality【4】. More recent research has further extended these findings, demonstrating that KPV prevents colitis-associated carcinogenesis in a PepT1-dependent manner【5】. A 2024 study combined KPV with FK506 in a nanoparticle formulation targeting PepT1, achieving synergistic reduction in disease activity index, improved colon length, and suppressed inflammatory cytokine production beyond what either agent achieved alone【6】. For a fully synergistic approach, explore our “KLOW” blend combining BPC-157, TB-500, GHK-Cu, and KPV―formulated strictly for research purposes.
Related product:
– KPV Peptide for Research
– “KLOW” – BPC-157/TB-500/GHK-Cu/KPV Blend
Effortless Skin Healing: How KPV Transforms Topical Recovery
Your skin, being the body’s front-line barrier, is continually challenged by environmental stressors. Persistent inflammation can lead to redness, itching, dermatitis, or even slow wound healing. KPV peptide, through its anti-inflammatory prowess, helps restore balance for healthier skin【7】.
As a fragment of alpha-msh, KPV suppresses the release of histamine, calms the cutaneous immune system, and hinders the oxidative stress that fuels chronic skin issues. A 2025 study demonstrated that KPV protects keratinocytes from particulate matter (PM10)-induced inflammation and apoptosis by suppressing MAPK (ERK and p38) and NF-κB pathways, reducing IL-1β secretion and reactive oxygen species, and modulating Bax/Bcl-2/caspase-3 expression【8】. Research on dermal delivery confirms that while passive skin penetration is limited, microneedle pretreatment and iontophoresis significantly enhance transdermal KPV flux for topical research applications【9】. These findings make KPV an exciting tool for research on eczema, psoriasis, and slow-healing wounds.
For advanced peptide healing research, synergistic blends like BPC-157/TB-500 and “KLOW” offer powerful multi-pathway support.
Mechanisms of Action: How KPV Peptide Calms Immunity & Fosters Healing
At the heart of KPV’s therapeutic potential is its modulation of the innate immune response:
$215.00Original price was: $215.00.$195.00Current price is: $195.00.– Blocks Pro-Inflammatory Cytokines: Key inflammatory messengers, including TNF-alpha and IL-1β, are downregulated【3】.
– Preserves Barrier Integrity: KPV helps maintain and restore tight junctions in both gut and skin epithelia―crucial for stopping the “leak” that inflames tissues.
– Reduces Oxidative Stress: As an alpha-msh-fragment, KPV chokes off free radicals in inflammation hotspots, reducing cell and DNA damage【8】.
– PepT1-Dependent Uptake: KPV is actively transported via the intestinal PepT1 transporter, achieving efficacy at nanomolar concentrations【3】【5】.
It’s no wonder scientists are exploring KPV across experimental models of IBD, dermatitis, and even post-surgical healing!
KPV and Immunity: Trustworthy Support Without Suppression
Chronic inflammation doesn’t just feel uncomfortable―it exhausts your immune defenses. KPV, rather than shutting the immune system down (like steroids), gently restores immune balance:
– Shifts immune cells from “attack mode” to “regulate and repair” mode.
– Limits overactivation of mast cells and histamine release―key for both gut and skin healing.
– Supports tissue regeneration for sustained, natural healing【2】【10】.
A 2023 comprehensive review in Cells confirmed that the melanocortin system, including KPV, exerts its anti-IBD effects through both MC1R-dependent and independent pathways, with PepT1 upregulation during active colitis further enhancing KPV’s bioavailability at sites of intestinal inflammation【10】. This makes KPV an ideal peptide for gut and skin immunity research.
Anti-Inflammatory Peptides vs. Traditional Anti-Inflammatories
$215.00Original price was: $215.00.$195.00Current price is: $195.00.Steroids, NSAIDs, and even some monoclonal antibodies can quash systemic inflammation but often come with tradeoffs―immune suppression, poor gut healing, or delayed wound closure. KPV, as a naturally occurring alpha-msh-fragment, provides a gentler approach. It works within your body’s own renewal systems, encouraging natural defense and repair without harsh side-effects.
Researchers have begun combining KPV with BPC-157 and TB-500 for more comprehensive results. Discover our BPC-157 Capsules and BPC-157/TB-500 Blend for parallel research lines.
KPV in Research: Cutting-Edge Discoveries & Future Promise
With growing evidence, KPV peptide is inspiring researchers across multiple fields:
– Gastroenterology: Studies confirm KPV reduces the severity of colitis and accelerates mucosal repair in animal models via PepT1-mediated NF-κB and MAPK suppression【3】【4】.
– Oncology: Research demonstrates KPV prevents colitis-associated carcinogenesis in a PepT1-dependent mechanism, suggesting potential in cancer prevention research【5】.
– Dermatology: KPV suppresses keratinocyte apoptosis and inflammation from environmental stressors and shows promise for eczema, psoriasis, and wound healing research【8】.
– Inflammation Science: KPV’s ability to quiet the NF-κB pathway via a receptor-independent mechanism sets it apart for labs investigating chronic inflammatory states【2】【10】.
Further research is exploring oral, topical, and injectable KPV protocols, plus synergistic blends. A 2024 peptide therapeutics review identified KPV as a leading candidate among gut-targeted anti-inflammatory peptides due to its PepT1 affinity and mucosal delivery potential【11】.
The Safety & Compliance Landscape: Only for Research Use
It’s crucial to stress: All products mentioned, including KPV, are strictly for research purposes and not for human or animal use. This ensures ethical compliance as the field advances.
$215.00Original price was: $215.00.$195.00Current price is: $195.00.How to Incorporate KPV Peptide in Research Studies
Studying KPV peptide is straightforward, thanks to its stability and solubility. Many labs pair KPV with bacteriostatic water for precision dosing in in vitro and animal studies. For combined pathway analysis, see our “KLOW” blend, or explore classic staples like BPC-157/TB-500.
Check OathPeptides.com’s KPV research-grade peptide and essential bacteriostatic water to prepare your samples with confidence.
Frequently Asked Questions About KPV Peptide
Q: What is the primary benefit of KPV peptide as an anti-inflammatory?
A: KPV peptide’s main benefit is its targeted ability to reduce inflammation by blocking pro-inflammatory cytokines and suppressing NF-κB and MAPK pathways without suppressing normal immune repair.
Q: How does KPV support gut healing?
A: By calming cytokine activity and restoring gut barrier integrity via PepT1-mediated transport, KPV helps reduce leaky gut, soothe irritation, and accelerate mucosal repair in research models.
Q: Can KPV peptide be used for skin healing?
A: Yes, in research settings KPV has shown promise in reducing skin irritation, protecting keratinocytes from oxidative stress-induced apoptosis, and supporting faster wound healing.
Q: Are KPV products intended for human or animal use?
A: No. All KPV peptides offered by OathPeptides.com are strictly for research purposes only.
Q: Which other peptides pair well with KPV in research studies?
A: KPV combines well with BPC-157, TB-500, and GHK-Cu for comprehensive tissue repair and anti-inflammatory studies. See our “KLOW” Blend for a research-ready solution.
Conclusion: Advancing Gut & Skin Healing Research with KPV Peptide
KPV peptide, as a powerful anti-inflammatory agent and alpha-msh-fragment, holds incredible potential for advancing gut and skin healing studies. Whether investigating new solutions for chronic inflammation or optimizing healing protocols, KPV’s unique immune-calming effect, demonstrated efficacy in experimental colitis and skin inflammation models, and synergy with peptides like BPC-157 and TB-500 make it an indispensable tool for peptide science.
Browse OathPeptides.com for KPV peptide and combinations like “KLOW” for your next inflammatory or regenerative research project. Remember: All products are strictly for research purposes and not for human or animal use.
References
1. Brzoska, T. et al. (2008). The immunomodulatory role of melanocortins in skin and gut inflammation. Endocrine. Link.
2. Getting, S.J., Schioth, H.B., & Perretti, M. (2003). Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. Journal of Pharmacology and Experimental Therapeutics, 306(2), 631–637. PMID 12750433.
3. Dalmasso, G., Charrier-Hisamuddin, L., Nguyen, H.T.T., Yan, Y., Sitaraman, S., & Merlin, D. (2008). PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Gastroenterology, 134(1), 166–178. PMID 18061177.
4. Kannengiesser, K., Maaser, C., Heidemann, J., et al. (2008). Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases, 14(3), 324–331. PMID 18092346.
5. Viennois, E., Ingersoll, S.A., Ayyadurai, S., et al. (2016). Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of KPV in a murine model. Cellular and Molecular Gastroenterology and Hepatology, 2(3), 340–357. PMID 27458604.
6. Zhang, D., Jiang, L., Yu, F., et al. (2024). PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of DSS-induced colitis. Frontiers in Pharmacology. DOI: 10.3389/fphar.2024.1442876.
7. Morandini, R. et al. (2006). The Role of α-MSH in the Regulation of Peripheral Inflammation. Peptides, 27(2): 339–348.
8. Unnamed authors (2025). Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. Food and Chemical Toxicology. Link.
9. Pawar, K. & Kolli, C.S. (2017). Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin. Journal of Pharmaceutical Sciences. PMID 28343991.
10. Gravina, A.G., Pellegrino, R., Durante, T., et al. (2023). The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials. Cells. PMID 37508552.
11. Ge, C., Wang, Z., Wang, Y., & Wei, M. (2024). Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions. Review. PMID 40686644.
Related Posts
KPV Peptide: Must-Have Anti-Inflammatory for Best Gut & Skin Healing
Looking for an anti-inflammatory that supports gut healing, radiant skin, and robust immunity? Discover how KPV peptide, a unique alpha-msh-fragment, offers powerful healing benefits without unwanted side effects.
Can Peptides Cause Immunogenicity?
Can peptides cause immunogenicity? Yes, peptides can trigger immune responses in some cases. Understanding this interaction between peptides and your immune system is crucial for both research and therapeutic applications. Let’s explore what you need to know about peptide immunogenicity. What Is Peptide Immunogenicity? Immunogenicity refers to your body’s immune response to a foreign substance. …
GH-Releasing Tesamorelin: Stunning Visceral Fat & Metabolism Boost
Discover how GH-releasing Tesamorelin powerfully targets stubborn visceral fat and supercharges metabolism, making it an exciting focus in body composition and peptide research. With its proven impact on lipolysis and IGF-1 levels, Tesamorelin offers researchers new insight into unlocking healthier metabolic pathways.